SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Amgen Inc – ‘10-Q’ for 9/30/14 – ‘R57’

On:  Wednesday, 10/29/14, at 4:46pm ET   ·   For:  9/30/14   ·   Accession #:  318154-14-22   ·   File #:  0-12477

Previous ‘10-Q’:  ‘10-Q’ on 8/5/14 for 6/30/14   ·   Next:  ‘10-Q’ on 4/27/15 for 3/31/15   ·   Latest:  ‘10-Q’ on 5/3/24 for 3/31/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/29/14  Amgen Inc                         10-Q        9/30/14   77:13M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    751K 
 2: EX-10.18    Agreement Between Amgen Inc. and Mr. David W.       HTML     87K 
                Meline                                                           
 3: EX-31       Rule 13A-14(A) Certifications                       HTML     36K 
 4: EX-32       Section 1350 Certifications                         HTML     25K 
51: R1          Document and Entity Information                     HTML     40K 
40: R2          Condensed Consolidated Statements of Income         HTML     86K 
                (Unaudited)                                                      
49: R3          Condensed Consolidated Statements of Comprehensive  HTML     47K 
                Income (Unaudited)                                               
54: R4          Condensed Consolidated Balance Sheets (Unaudited)   HTML    100K 
71: R5          Condensed Consolidated Balance Sheets (Unaudited)   HTML     29K 
                (Parenthetical)                                                  
42: R6          Condensed Consolidated Statements of Cash Flows     HTML    112K 
                (Unaudited)                                                      
48: R7          Summary of significant accounting policies          HTML     35K 
36: R8          Restructuring                                       HTML     64K 
26: R9          Business combinations                               HTML     58K 
72: R10         Income taxes                                        HTML     33K 
56: R11         Earnings per share                                  HTML     55K 
55: R12         Available-for-sale investments                      HTML    225K 
61: R13         Inventories                                         HTML     31K 
62: R14         Goodwill and other intangible assets                HTML     87K 
59: R15         Financing arrangements                              HTML     76K 
63: R16         Stockholders' equity                                HTML    148K 
50: R17         Fair value measurement                              HTML    224K 
53: R18         Derivative instruments                              HTML    172K 
58: R19         Contingencies and commitments                       HTML     34K 
77: R20         Summary of significant accounting policies          HTML     52K 
                (Policies)                                                       
67: R21         Restructuring (Tables)                              HTML     62K 
45: R22         Business combinations (Tables)                      HTML     46K 
57: R23         Earnings per share (Tables)                         HTML     52K 
47: R24         Available-for-sale investments (Tables)             HTML    225K 
19: R25         Inventories (Tables)                                HTML     30K 
68: R26         Goodwill and other intangible assets (Tables)       HTML     76K 
74: R27         Financing arrangements (Tables)                     HTML     75K 
31: R28         Stockholders' equity (Tables)                       HTML    140K 
30: R29         Fair value measurement (Tables)                     HTML    200K 
34: R30         Derivative instruments (Tables)                     HTML    156K 
35: R31         Summary of significant accounting policies          HTML     25K 
                (Details)                                                        
37: R32         Restructuring (Details Textual)                     HTML     35K 
17: R33         Restructuring (Details)                             HTML     40K 
65: R34         Restructuring (Details 1)                           HTML     32K 
44: R35         Business combinations (Details)                     HTML     27K 
46: R36         Business combinations (Details 1)                   HTML     60K 
22: R37         Business combinations (Details 2)                   HTML     27K 
76: R38         Business combinations (Details Textual)             HTML     57K 
11: R39         Income taxes (Details)                              HTML     37K 
38: R40         Earnings per share (Details)                        HTML     44K 
70: R41         Available-for-sale investments (Details)            HTML     56K 
21: R42         Available-for-sale investments (Details 1)          HTML     39K 
29: R43         Available-for-sale investments (Details 2)          HTML     42K 
33: R44         Available-for-sale investments Available-for-sale   HTML     52K 
                investments (Details 3)                                          
41: R45         Available-for-sale investments (Details Textual)    HTML     33K 
16: R46         Inventories (Details)                               HTML     33K 
25: R47         Goodwill and other intangible assets (Details)      HTML     29K 
13: R48         Goodwill and other intangible assets (Details 1)    HTML     46K 
69: R49         Goodwill and other intangible assets (Details       HTML     45K 
                Textual)                                                         
20: R50         Financing arrangements (Details)                    HTML    116K 
66: R51         Stockholders' equity (Details Textual)              HTML     33K 
23: R52         Stockholders' equity (Details 1)                    HTML     86K 
39: R53         Stockholders' equity (Details 2)                    HTML     45K 
12: R54         Fair value measurement (Details)                    HTML    140K 
15: R55         Fair value measurement Fair value measurement       HTML     28K 
                (Details 1)                                                      
32: R56         Fair value measurements (Details Textual)           HTML     50K 
18: R57         Derivative instruments (Details)                    HTML     27K 
73: R58         Derivative instruments (Details 1)                  HTML     27K 
43: R59         Derivative instruments (Details 2)                  HTML     39K 
60: R60         Derivative instruments (Details 3)                  HTML     25K 
24: R61         Derivative instruments (Details 4)                  HTML     41K 
27: R62         Derivative instruments (Details Textual)            HTML     49K 
64: R63         Contingencies and commitments (Details)             HTML     22K 
75: XML         IDEA XML File -- Filing Summary                      XML    113K 
14: EXCEL       IDEA Workbook of Financial Reports                  XLSX    257K 
28: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   2.31M 
 5: EX-101.INS  XBRL Instance -- amgn-20140930                       XML   3.59M 
 7: EX-101.CAL  XBRL Calculations -- amgn-20140930_cal               XML    234K 
 8: EX-101.DEF  XBRL Definitions -- amgn-20140930_def                XML    665K 
 9: EX-101.LAB  XBRL Labels -- amgn-20140930_lab                     XML   1.62M 
10: EX-101.PRE  XBRL Presentations -- amgn-20140930_pre              XML    969K 
 6: EX-101.SCH  XBRL Schema -- amgn-20140930                         XSD    183K 
52: ZIP         XBRL Zipped Folder -- 0000318154-14-000022-xbrl      Zip    262K 


‘R57’   —   Derivative instruments (Details)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v2.4.0.8
Derivative instruments (Details) (Cash flow hedge [Member], Cross currency swap contracts [Member])
In Millions, unless otherwise specified
2.125% euro denominated notes due 2019 (2.125% 2019 euro Notes) [Member]
USD ($)
2.125% euro denominated notes due 2019 (2.125% 2019 euro Notes) [Member]
EUR (€)
2.125% euro denominated notes due 2019 (2.125% 2019 euro Notes) [Member]
Interest rate received [Member]
2.125% euro denominated notes due 2019 (2.125% 2019 euro Notes) [Member]
Interest rate paid [Member]
5.50% pound sterling denominated notes due 2026 (5.50% 2026 pound sterling Notes) [Member]
USD ($)
5.50% pound sterling denominated notes due 2026 (5.50% 2026 pound sterling Notes) [Member]
GBP (£)
5.50% pound sterling denominated notes due 2026 (5.50% 2026 pound sterling Notes) [Member]
Interest rate received [Member]
5.50% pound sterling denominated notes due 2026 (5.50% 2026 pound sterling Notes) [Member]
Interest rate paid [Member]
4.00% pound sterling denominated notes due 2029 (4.00% 2029 pound sterling Notes) [Member]
USD ($)
4.00% pound sterling denominated notes due 2029 (4.00% 2029 pound sterling Notes) [Member]
GBP (£)
4.00% pound sterling denominated notes due 2029 (4.00% 2029 pound sterling Notes) [Member]
Interest rate received [Member]
4.00% pound sterling denominated notes due 2029 (4.00% 2029 pound sterling Notes) [Member]
Interest rate paid [Member]
Derivative [Line Items]                        
Notional amount $ 864 € 675     $ 748 £ 475     $ 1,122 £ 700    
Interest rate     2.125% 2.60%     5.50% 5.80%     4.00% 4.30%

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:10/29/144
For Period end:9/30/14
 List all Filings 
Top
Filing Submission 0000318154-14-000022   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 2:30:02.3am ET